Cargando…

The intersections of industry with the health research enterprise

There is increased awareness of the negative impact of large multinational corporations – the ‘industry’ – on public health. These corporations have established different types of relationships with a number of actors in the field of health research. This Commentary explores the different types of r...

Descripción completa

Detalles Bibliográficos
Autores principales: Akl, Elie A., Khamis, Assem M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542139/
https://www.ncbi.nlm.nih.gov/pubmed/31142343
http://dx.doi.org/10.1186/s12961-019-0457-7
_version_ 1783422891441782784
author Akl, Elie A.
Khamis, Assem M.
author_facet Akl, Elie A.
Khamis, Assem M.
author_sort Akl, Elie A.
collection PubMed
description There is increased awareness of the negative impact of large multinational corporations – the ‘industry’ – on public health. These corporations have established different types of relationships with a number of actors in the field of health research. This Commentary explores the different types of relationships between the industry and the actors of health research, how they intersect with the different research steps, and how these relationships allow the industry to exert influence. The types of relationships discussed consist of funding of research, direct relationships with the actors of research (namely advocacy groups, funding agencies, experts, professional organisations, regulatory agencies and health practitioners), and the influencing research standards. The potentially influenced research steps either precede the research (i.e. the prioritisation of research question), relate to it directly (i.e. its planning, conduct, reporting, dissemination and evaluation), or build on it (i.e. regulatory approval, integration into guidelines and adoption into practice). In conclusion, the industry has successfully fostered relationships with almost every actor of the health research enterprise and is using these relationships to influence the different steps of health research. The degree of influence the industry is having on health research calls for more work on managing the relationships discussed herein.
format Online
Article
Text
id pubmed-6542139
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-65421392019-06-04 The intersections of industry with the health research enterprise Akl, Elie A. Khamis, Assem M. Health Res Policy Syst Commentary There is increased awareness of the negative impact of large multinational corporations – the ‘industry’ – on public health. These corporations have established different types of relationships with a number of actors in the field of health research. This Commentary explores the different types of relationships between the industry and the actors of health research, how they intersect with the different research steps, and how these relationships allow the industry to exert influence. The types of relationships discussed consist of funding of research, direct relationships with the actors of research (namely advocacy groups, funding agencies, experts, professional organisations, regulatory agencies and health practitioners), and the influencing research standards. The potentially influenced research steps either precede the research (i.e. the prioritisation of research question), relate to it directly (i.e. its planning, conduct, reporting, dissemination and evaluation), or build on it (i.e. regulatory approval, integration into guidelines and adoption into practice). In conclusion, the industry has successfully fostered relationships with almost every actor of the health research enterprise and is using these relationships to influence the different steps of health research. The degree of influence the industry is having on health research calls for more work on managing the relationships discussed herein. BioMed Central 2019-05-29 /pmc/articles/PMC6542139/ /pubmed/31142343 http://dx.doi.org/10.1186/s12961-019-0457-7 Text en © The Author(s). 2019 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Commentary
Akl, Elie A.
Khamis, Assem M.
The intersections of industry with the health research enterprise
title The intersections of industry with the health research enterprise
title_full The intersections of industry with the health research enterprise
title_fullStr The intersections of industry with the health research enterprise
title_full_unstemmed The intersections of industry with the health research enterprise
title_short The intersections of industry with the health research enterprise
title_sort intersections of industry with the health research enterprise
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6542139/
https://www.ncbi.nlm.nih.gov/pubmed/31142343
http://dx.doi.org/10.1186/s12961-019-0457-7
work_keys_str_mv AT akleliea theintersectionsofindustrywiththehealthresearchenterprise
AT khamisassemm theintersectionsofindustrywiththehealthresearchenterprise
AT akleliea intersectionsofindustrywiththehealthresearchenterprise
AT khamisassemm intersectionsofindustrywiththehealthresearchenterprise